These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

80 related items for PubMed ID: 10801370

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Meta-analysis of randomized, controlled clinical trials in angiogenesis: gene and cell therapy in peripheral arterial disease.
    De Haro J, Acin F, Lopez-Quintana A, Florez A, Martinez-Aguilar E, Varela C.
    Heart Vessels; 2009 Sep; 24(5):321-8. PubMed ID: 19784813
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. The action of dipyridamole to prevent thrombosis: practical implications for the treatment and prevention of stroke.
    Booze CD, Serebruany VL.
    Curr Treat Options Cardiovasc Med; 2006 May; 8(3):221-7. PubMed ID: 16635441
    [Abstract] [Full Text] [Related]

  • 46. Peripheral vascular disease endovascular management in patients scheduled for cardiac surgery: a clinical-angiographic approach.
    Rigatelli G, Cardaioli P, Giordan M, Roncon L, Faggian G, Rigatelli G, Zonzin P.
    Int J Cardiovasc Imaging; 2006 May; 22(3-4):305-10. PubMed ID: 16525753
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Antithrombotic drugs in the primary medical management of intermittent claudication: a meta-analysis.
    Girolami B, Bernardi E, Prins MH, ten Cate JW, Prandoni P, Hettiarachchi R, Marras E, Stefani PM, Girolami A, Büller HR.
    Thromb Haemost; 1999 May; 81(5):715-22. PubMed ID: 10365743
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. The effects of oral anticoagulants in patients with peripheral arterial disease: rationale, design, and baseline characteristics of the Warfarin and Antiplatelet Vascular Evaluation (WAVE) trial, including a meta-analysis of trials.
    WAVE Investigators.
    Am Heart J; 2006 Jan; 151(1):1-9. PubMed ID: 16368284
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Antithrombotic drugs in the primary medical management of intermittent claudication: a meta-analysis.
    Girolami B, Bernardi E, Prins MH, ten Cate JW, Prandoni P, Hettiarachchi R, Marras E, Stefani PM, Girolami A, Büller HR.
    Thromb Haemost; 1999 May; 81(5):715-22. PubMed ID: 10365743
    [Abstract] [Full Text] [Related]

  • 55. Safety and efficacy evaluation of clopidogrel compared to ticlopidine after stent implantation: an updated meta-analysis.
    Casella G, Ottani F, Pavesi PC, Sangiorgio P, Rubboli A, Galvani M, Fontanelli A, Bracchetti D.
    Ital Heart J; 2003 Oct; 4(10):677-84. PubMed ID: 14664280
    [Abstract] [Full Text] [Related]

  • 56. The effects of oral anticoagulants in patients with peripheral arterial disease: rationale, design, and baseline characteristics of the Warfarin and Antiplatelet Vascular Evaluation (WAVE) trial, including a meta-analysis of trials.
    WAVE Investigators.
    Am Heart J; 2006 Jan; 151(1):1-9. PubMed ID: 16368284
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.